- Filed
- Apr 12, 2024 12:00 AM ET
- Period of report
- —
On SEC.gov
Financials in this filing
| Metric | Period | Value |
|---|---|---|
| Shares Outstanding | Q2 2024 · Apr 10, 2024 | 53.2M sh |
| Short Term Investments | Q2 2024 · Feb 29, 2024 | $4M |
| Short Term Investments | Q2 2024 · Aug 31, 2023 | $5.5M |
| Cash And Equivalents | Q2 2024 · Feb 29, 2024 | $1.2M |
| Cash And Equivalents | Q2 2024 · Aug 31, 2023 | $492.61K |
| Current Liabilities | Q2 2024 · Feb 29, 2024 | $225.61K |
| Current Liabilities | Q2 2024 · Aug 31, 2023 | $287.23K |
| Total Liabilities | Q2 2024 · Feb 29, 2024 | $225.61K |
| Total Liabilities | Q2 2024 · Aug 31, 2023 | $287.23K |
| Current Assets | Q2 2024 · Feb 29, 2024 | $5.37M |
| Current Assets | Q2 2024 · Aug 31, 2023 | $6.3M |
| Total Assets | Q2 2024 · Feb 29, 2024 | $6.68M |
| Total Assets | Q2 2024 · Aug 31, 2023 | $7.62M |
| Shares Diluted | Q2 2024 · Feb 28, 2023 | 53.2M sh |
| Shares Diluted | Q2 2024 · Feb 28, 2023 | 53.2M sh |
| Operating Cash Flow | Q2 2024 · Feb 28, 2023 | −$1.01M |
| Stockholders Equity | Q2 2024 · Feb 28, 2023 | $8.43M |
| Stockholders Equity | Q2 2024 · Nov 30, 2022 | $8.93M |
| Stockholders Equity | Q2 2024 · Aug 31, 2022 | $9.57M |
| Eps Diluted | Q2 2024 · Feb 28, 2023 | −$0.01 |
| Eps Diluted | Q2 2024 · Feb 28, 2023 | −$0.02 |
| Eps Basic | Q2 2024 · Feb 28, 2023 | −$0.01 |
| Eps Basic | Q2 2024 · Feb 28, 2023 | −$0.02 |
| Sga Expense | Q2 2024 · Feb 28, 2023 | $359.6K |
| Sga Expense | Q2 2024 · Feb 28, 2023 | $744.09K |
| Rd Expense | Q2 2024 · Feb 28, 2023 | $180.3K |
| Rd Expense | Q2 2024 · Feb 28, 2023 | $396.87K |
| Operating Income | Q2 2024 · Feb 28, 2023 | −$539.9K |
| Operating Income | Q2 2024 · Feb 28, 2023 | −$1.14M |